334 related articles for article (PubMed ID: 24098708)
1. MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.
Lo TF; Tsai WC; Chen ST
PLoS One; 2013; 8(9):e75628. PubMed ID: 24098708
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
3. Methionine adenosyltransferases in liver cancer.
Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
[TBL] [Abstract][Full Text] [Related]
4. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells.
Cai J; Mao Z; Hwang JJ; Lu SC
Cancer Res; 1998 Apr; 58(7):1444-50. PubMed ID: 9537246
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting
Simile MM; Peitta G; Tomasi ML; Brozzetti S; Feo CF; Porcu A; Cigliano A; Calvisi DF; Feo F; Pascale RM
Oncotarget; 2019 Apr; 10(29):2835-2854. PubMed ID: 31073374
[TBL] [Abstract][Full Text] [Related]
7. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.
Nordgren KK; Peng Y; Pelleymounter LL; Moon I; Abo R; Feng Q; Eckloff B; Yee VC; Wieben E; Weinshilboum RM
Drug Metab Dispos; 2011 Nov; 39(11):2135-47. PubMed ID: 21813468
[TBL] [Abstract][Full Text] [Related]
8. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
9. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma.
Martínez-Chantar ML; García-Trevijano ER; Latasa MU; Martín-Duce A; Fortes P; Caballería J; Avila MA; Mato JM
Gastroenterology; 2003 Apr; 124(4):940-8. PubMed ID: 12671891
[TBL] [Abstract][Full Text] [Related]
10. Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta.
Ramani K; Yang H; Xia M; Ara AI; Mato JM; Lu SC
Hepatology; 2008 Feb; 47(2):521-31. PubMed ID: 18041713
[TBL] [Abstract][Full Text] [Related]
11. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
[TBL] [Abstract][Full Text] [Related]
12. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
[TBL] [Abstract][Full Text] [Related]
13. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
Yang H; Magilnick N; Noureddin M; Mato JM; Lu SC
J Cell Physiol; 2007 Mar; 210(3):766-73. PubMed ID: 17154373
[TBL] [Abstract][Full Text] [Related]
14. Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice.
Li J; Ramani K; Sun Z; Zee C; Grant EG; Yang H; Xia M; Oh P; Ko K; Mato JM; Lu SC
Am J Pathol; 2010 May; 176(5):2456-66. PubMed ID: 20363925
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
Yang H; Cho ME; Li TW; Peng H; Ko KS; Mato JM; Lu SC
J Clin Invest; 2013 Jan; 123(1):285-98. PubMed ID: 23241961
[TBL] [Abstract][Full Text] [Related]
16. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.
Liu Q; Chen J; Liu L; Zhang J; Wang D; Ma L; He Y; Liu Y; Liu Z; Wu J
J Biol Chem; 2011 May; 286(19):17168-80. PubMed ID: 21247894
[TBL] [Abstract][Full Text] [Related]
17. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
18. Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
Pascale RM; Peitta G; Simile MM; Feo F
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234428
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
Komoll RM; Hu Q; Olarewaju O; von Döhlen L; Yuan Q; Xie Y; Tsay HC; Daon J; Qin R; Manns MP; Sharma AD; Goga A; Ott M; Balakrishnan A
J Hepatol; 2021 Jan; 74(1):122-134. PubMed ID: 32738449
[TBL] [Abstract][Full Text] [Related]
20. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
Qi Y; Yao X; Du X
IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]